Follow
Trevor A. Zandi
Trevor A. Zandi
Postdoctoral Scholar, Novartis Institutes for Biomedical Research, Broad Institute of Harvard and MIT
Verified email at novartis.com
Title
Cited by
Cited by
Year
Non-classical transpeptidases yield insight into new antibacterials
P Kumar, A Kaushik, EP Lloyd, SG Li, R Mattoo, NC Ammerman, DT Bell, ...
Nature chemical biology 13 (1), 54-61, 2017
1292017
Phylogenetic and Biochemical Analyses of Mycobacterial l,d-Transpeptidases Reveal a Distinct Enzyme Class That Is Preferentially Acylated by Meropenem
TA Zandi, RL Marshburn, PK Stateler, LA Brammer Basta
ACS infectious diseases 5 (12), 2047-2054, 2019
152019
Competing off-loading mechanisms of meropenem from an l,d-transpeptidase reduce antibiotic effectiveness
TA Zandi, CA Townsend
Proceedings of the National Academy of Sciences 118 (27), e2008610118, 2021
142021
Structure–Activity Relationship of Penem Antibiotic Side Chains Used against Mycobacteria Reveals Highly Active Compounds
HR Batchelder, TA Zandi, A Kaushik, A Naik, E Story-Roller, ...
ACS Infectious Diseases, 2022
42022
EVOLUTION, FUNCTION, AND INHIBITION OF L, D TRANSPEPTIDASE ENZYMES OF MYCOBACTERIA
TA Zandi
Johns Hopkins University, 2022
2022
Biochemical and structural analyses of mycobacterial L, D-transpeptidases
T Zandi, P Stateler, R Marshburn, L Basta
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 257, 2019
2019
Investigating the roles of Mycobacterium smegmatis L, D-transpeptidases in cell wall biosynthesis
R Marshburn, P Stateler, T Zandi, L Basta
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 255, 2018
2018
Supporting Information. Phylogenetic and biochemical analyses of mycobacterial L, D-transpeptidases reveal a distinct enzyme class that is preferentially acylated by meropenem.
TA Zandi, RL Marshburn, PK Stateler, LAB Basta
The system can't perform the operation now. Try again later.
Articles 1–8